Target intelligence / Profile preview

URB2 ribosome biogenesis homolog (URB2)

Target
URB2
Molecular classification
Other (ribosome biogenesis factor), Not an enzyme, receptor, transporter, or classical signaling protein
01

Overview

URB2 ribosome biogenesis homolog (**URB2**) is a protein involved in the critical process of ribosome biogenesis in eukaryotic cells, specifically participating in the processing of 27S pre-rRNA and the biogenesis of the large (60S) ribosomal subunit[2][3][6]. It is highly expressed during hematopoietic stem cell expansion and plays an essential role in supporting the proliferation and survival of these cells by regulating ribosome assembly and protein synthesis through the p53 pathway in specific biological contexts, such as in zebrafish hematopoiesis[1][2]. URB2 is classified as a **ribosome biogenesis factor**, not as a receptor, enzyme, transporter, or transcription factor. Mutations or deficiencies in URB2 can impair stem cell development and are associated with disrupted ribosome assembly, connecting it to disorders known as ribosomopathies (such as some bone marrow failure syndromes)[1][2]. There is currently no known drug that targets URB2, it is not established as a therapeutic target in pharmacology, and there are no validated biomarkers or specific safety concerns directly tied to its modulation. This entry refers to the human gene URB2, with high sequence conservation across eukaryotes[3][5].

Other names
Unhealthy ribosome biogenesis protein 2 homologRibosome biogenesis protein Urb2
02

Biological functions

Ribosome biogenesis27S pre-rRNA processing60S ribosomal subunit biogenesisRegulation of hematopoietic stem cell development via p53 pathwayRegulation of cell proliferation and apoptosis
03

Disease associations

Other (ribosomopathies, developmental disorders related to defective ribosome synthesis, potentially contributes to hematopoietic disorders)

Beyond the preview

Go deeper on URB2 ribosome biogenesis homolog (URB2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on URB2 ribosome biogenesis homolog (URB2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call